Long-term morphine treatment increases Ku protein DNA end-binding activity

NeuroReport

Volumn 8, Issue 9-10, 1997, Pages 2143-2148

  Bakalkin, Georgy ^a   Yakovleva, Tatjana ^a   Melzig, Matthias ^b   Terenius, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

DNA end binding factor; Morphine; Protein Ku

Indexed keywords

DNA BINDING PROTEIN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MORPHINE; NALOXONE; PEPTIDE YY; PROTEIN KINASE; SPERMIDINE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LONG TERM CARE; LUNG SMALL CELL CANCER; NERVE CELL PLASTICITY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ANTIGENS, NUCLEAR; DNA HELICASES; DNA-BINDING PROTEINS; HUMANS; MORPHINE; NUCLEAR PROTEINS; SPERMIDINE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030755920     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Garcia MM, Brown HE and Harlan RE. Brain Res 692, 23-40 (1995).
2. Nye HE and Nestler EJ. Mol Pharmacol 49, 636-645, (1996).
3. Chang SL, Zadina JE and Spriggs L et al. Mol Cell Neurosci 4, 25-29 (1993).
4. Osugi T, Ding Y, Tanaka H et al. FEBS Lett 391, 11-16 (1996).
5. Ye J, Cippitelli M, Dorman L et al. Mol Cell Biol 16, 4744-4753 (1996).
6. Zhou Q, Gedrich RW and Engel DA. J Virol 69, 4323-4330 (1995).
7. Geijer T, Bergh J and Terenius L. Reg Peptides 34, 181-188 (1991).
8. Pählman S, Ruusala A-I, Abrahamson L et al. Cell Diff 14, 135-144 (1984).
9. Bakalkin G, Yakovleva T and Terenius L. Mol Brain Res 20, 137-146 (1993).
10. Bakalkin G, Telkov M, Yakovleva T et al. Proc Natl Acad Sci USA 92, 9024-9028 (1995).
11. Kato Y, Kato T, Ezashi T et al. Biochem Biophys Res Commun 195, 963-968 (1993).
12. Bakalkin G, Yakovleva T and Terenius L. Biochem Biophys Res Commun 231, 135-139 (1997).
13. Gottlieb TM and Jackson SP. Cell 72, 131-142 (1993).
14. Bakalkin G, Yakovleva T, Selivanova G et al. Proc Natl Acad Sci USA 91, 413-417 (1994).
15. Blunt T, Finnie NJ, Taccioli GE et al. Cell 80, 813-823 (1995).
16. Giffin W, Torrance H, Rodda DJ et al. Nature 380, 265-268 (1996).
17. Fried LM, Koumenis C, Peterson SR et al. Proc Natl Acad Sci USA 93, 13825-13830 (1996).
18. Belcheva M, Barg J, Clark WG et al. J Neurosci 13, 104-114 (1993).
19. Cruciani RA, Dvorkin B and Morris SA et al. Proc Natl Acad Sci USA 90, 3019-3023 (1993).
20. Smart D, Smith G and Lambert DG. J Neurochem 62, 1009-1014 (1994).
21. Fukuda K, Kato S, Morikawa H et al. J Neurochem 67, 1309-1316 (1996).
22. Hauser KF and Stiene-Martin A. In: Hammer RP Jr, ed. Neurobiology of Opiates. Boca Raton, Florida: CRC Press, 1993: 23-61.
23. Maneckjee R and Minna JD. Proc Natl Acad Sci USA 89, 1169-1173 (1992).
24. Zagon IS, Goodman SR and McLaughlin PJ. Brain Res 482, 297-305 (1989).